{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:43:36Z","timestamp":1793321016736,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.autrev.2013.06.004","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T05:17:44Z","timestamp":1371273464000},"page":"3-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":883,"title":["Innate and adaptive immunity in inflammatory bowel disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Alessandra","family":"Geremia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Biancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino R.","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.06.004_bb0005","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.06.004_bb0010","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0015","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0025","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5","volume":"157","author":"Fuss","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/egh.11.107","article-title":"The IL-23\/IL-17 pathway in inflammatory bowel disease","volume":"6","author":"Geremia","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","article-title":"Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection","volume":"131","author":"Van der Sluis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0045","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1069094","article-title":"Colorectal cancer in mice genetically deficient in the mucin Muc2","volume":"295","author":"Velcich","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.06.004_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00054725-199902000-00004","article-title":"Abnormalities in mucin gene expression in Crohn's disease","volume":"5","author":"Buisine","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0060","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ng.483","article-title":"Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0070","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.molimm.2007.02.007","article-title":"Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines","volume":"44","author":"Uehara","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00054725-200307000-00001","article-title":"Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis","volume":"9","author":"Wehkamp","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0080","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0505256102","article-title":"Reduced Paneth cell alpha-defensins in ileal Crohn's disease","volume":"102","author":"Wehkamp","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2013.06.004_bb0085","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/gut.2003.032805","article-title":"NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression","volume":"53","author":"Wehkamp","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2013.06.004_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2011.01039.x","article-title":"Intracellular sensors of extracellular bacteria","volume":"243","author":"Clarke","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2013.06.004_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"issue":"6837","key":"10.1016\/j.autrev.2013.06.004_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.06.004_bb0115","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1572-0241.2004.40304.x","article-title":"Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis","volume":"99","author":"Economou","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s100380200067","article-title":"Absence of mutation in the NOD2\/CARD15 gene among 483 Japanese patients with Crohn's disease","volume":"47","author":"Yamazaki","year":"2002","journal-title":"J Hum Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0125","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.MIB.0000171279.05471.21","article-title":"Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease","volume":"11","author":"Kugathasan","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.MIB.0000225332.83861.5f","article-title":"Functional consequences of NOD2 (CARD15) mutations","volume":"12","author":"Abraham","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni1092","article-title":"NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses","volume":"5","author":"Watanabe","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ni.1722","article-title":"A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1","volume":"10","author":"Noguchi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0145","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","article-title":"Genomewide association study of leprosy","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ibd.20066","article-title":"NOD2\/CARD15 disease associations other than Crohn's disease","volume":"13","author":"Henckaerts","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","article-title":"A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1","volume":"39","author":"Hampe","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0160","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng2061","article-title":"Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility","volume":"39","author":"Parkes","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0165","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/emboj.2008.31","article-title":"Toll-like receptors control autophagy","volume":"27","author":"Delgado","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2013.06.004_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm.2069","article-title":"NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation","volume":"16","author":"Cooney","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","article-title":"Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry","volume":"11","author":"Travassos","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0180","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/j.gastro.2011.02.048","article-title":"Autophagy, microbial sensing, endoplasmic reticulum stress and epithelial function in inflammatory bowel disease","volume":"140","author":"Kaser","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0185","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gut.2003.034033","article-title":"Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis","volume":"53","author":"Vermeire","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0190","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00054725-200409000-00004","article-title":"A genome scan in 260 inflammatory bowel disease-affected relative pairs","volume":"10","author":"Barmada","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0195","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1086\/302294","article-title":"A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort","volume":"64","author":"Hampe","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0200","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.cell.2008.07.021","article-title":"XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease","volume":"134","author":"Kaser","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2013.06.004_bb0205","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.autrev.2013.06.004_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0215","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"Burton","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0220","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0225","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ng.145","article-title":"Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease","volume":"40","author":"Fisher","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0230","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ng.148","article-title":"Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis","volume":"40","author":"Franke","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2013.06.004_bb0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0245","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.06.004_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20091509","article-title":"Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+lineage distinct from conventional natural killer cells","volume":"207","author":"Crellin","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20092029","article-title":"IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors","volume":"207","author":"Satoh-Takayama","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0260","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2013.06.004_bb0265","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.20101712","article-title":"IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease","volume":"208","author":"Geremia","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.iy.12.040194.001303","article-title":"Lymphokine production by human T cells in disease states","volume":"12","author":"Romagnani","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4049\/jimmunol.163.1.143","article-title":"Bioactive IL-18 expression is up-regulated in Crohn's disease","volume":"163","author":"Monteleone","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0290","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(97)70128-8","article-title":"Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells","volume":"112","author":"Monteleone","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0295","first-page":"127","article-title":"Intereukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa","volume":"78","author":"Breese","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0300","first-page":"52","article-title":"Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease","volume":"8","author":"Noguchi","year":"1995","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00054725-199811000-00005","article-title":"Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease","volume":"4","author":"Camoglio","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0310","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0315","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.06.004_bb0320","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ibd.21735","article-title":"New pathogenic paradigms in inflammatory bowel disease","volume":"18","author":"Di Sabatino","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0325","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/gut.2009.182170","article-title":"Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease","volume":"58","author":"Rovedatti","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0330","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1006\/cyto.2000.0744","article-title":"Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease","volume":"12","author":"Vainer","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2013.06.004_bb0335","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00054725-200409000-00014","article-title":"Intestinal interleukin-13 in pediatric inflammatory bowel disease patients","volume":"10","author":"Kadivar","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0340","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2010.09.047","article-title":"Colitis and intestinal inflammation in IL10\u2212\/\u2212 mice results from IL-13R\u03b12-mediated attenuation of IL-13 activity","volume":"140","author":"Wilson","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0345","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.201142327","article-title":"IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and T cells they stimulate","volume":"42","author":"Bernardo","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0350","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0355","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/ibd.21248","article-title":"IL-23\/IL-17 axis in IBD","volume":"16","author":"Sarra","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0360","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0365","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0370","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2007.135053","article-title":"IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn's disease","volume":"57","author":"Kobayashi","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0375","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2249.2010.04093.x","article-title":"The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease","volume":"160","author":"Sugihara","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0385","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","article-title":"Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease","volume":"128","author":"Monteleone","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0390","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/ibd.21238","article-title":"Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases","volume":"16","author":"Sarra","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0395","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2008.01.041","article-title":"Regulation of gut inflammation and Th17 cell response by interleukin-21","volume":"134","author":"Fina","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0400","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O'Garra","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.06.004_bb0410","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.2005.072801","article-title":"Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis","volume":"55","author":"Fantini","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0415","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-065X.2001.1820115.x","article-title":"Control of intestinal inflammation by regulatory T cells","volume":"182","author":"Singh","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2013.06.004_bb0420","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s10620-008-0590-6","article-title":"Diminution of circulating CD4+CD25 high T cells in na\u00efve Crohn's disease","volume":"54","author":"Chamouard","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2013.06.004_bb0425","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","article-title":"Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease","volume":"128","author":"Maul","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0430","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clim.2007.08.003","article-title":"Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease","volume":"125","author":"Saruta","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0435","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10875-009-9345-1","article-title":"Foxp3+ regulatory T cells Th17 effector cells, and cytokine environment in inflammatory bowel disease","volume":"30","author":"Eastaff-Leung","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0440","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI12821","article-title":"Blocking Smad7 restores TGF-\u03b21 signaling in chronic inflammatory bowel disease","volume":"108","author":"Monteleone","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.06.004_bb0445","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20040685","article-title":"T cells that cannot respond to TGF-\u03b2 escape control by CD4(+)CD25(+) regulatory T cells","volume":"201","author":"Fahlen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0450","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2008.12.053","article-title":"Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression","volume":"136","author":"Fantini","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2013.06.004_bb0455","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coi.2009.05.021","article-title":"Developmental plasticity of Th17 and Treg cells","volume":"21","author":"Lee","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0460","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.39.2.284","article-title":"Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation","volume":"39","author":"Pender","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0465","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.4049\/jimmunol.0802887","article-title":"Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits Th1 cytokine production and T-box transcription factor T-bet in inflammatory bowel disease","volume":"183","author":"Di Sabatino","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0470","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mi.2011.18","article-title":"The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease","volume":"4","author":"Di Sabatino","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0475","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00441-012-1390-z","article-title":"Proteases and the gut barrier","volume":"351","author":"Biancheri","year":"2013","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2013.06.004_bb0480","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/ibd.22967","article-title":"What's the next best cytokine target in IBD?","volume":"18","author":"Macdonald","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2013.06.004_bb0485","doi-asserted-by":"crossref","first-page":"29132","DOI":"10.1074\/jbc.M003516200","article-title":"Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement","volume":"275","author":"Ceponis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2013.06.004_bb0490","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/labinvest.3700316","article-title":"Inflammatory processed have differential effects on claudins 2, 3 and 4 in colonic epithelial cells","volume":"85","author":"Prasad","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2013.06.004_bb0495","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2013.06.004_bb0500","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.4049\/jimmunol.162.9.5337","article-title":"NF-kappa B-inducing kinase is a common mediator of IL-17-, TNFalpha-, and IL-1beta-induced chemokine promoter activation in intestinal epithelial cells","volume":"162","author":"Awane","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0505","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"IL-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2013.06.004_bb0510","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2013.06.004_bb0515","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1110-1194","article-title":"Inside the microbial and immune labyrinth: totally gutted","volume":"16","author":"Macdonald","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2013.06.004_bb0520","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.gastrohep.2011.08.003","article-title":"New knowledge in genetics and inflammatory bowel disease. Are there any practical applications?]","volume":"34","author":"Iborra","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2013.06.004_bb0525","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2013.06.004_bb9000","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T07:45:50Z","timestamp":1688283950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213001043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1568997213001043"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.06.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate and adaptive immunity in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}